Literature DB >> 17131327

Reproductive risk factors for incident bladder cancer: Iowa Women's Health Study.

Anna E Prizment1, Kristin E Anderson, Bernard L Harlow, Aaron R Folsom.   

Abstract

We studied the association between reproductive factors and bladder cancer incidence in a prospective cohort study of 37,459 Iowa women aged 55-69 years and initially free from cancer in 1986. Women reported reproductive history and were followed prospectively through 2003. After adjusting for age and smoking, there was an inverse association between age at menopause and incident bladder cancer (n = 192). Compared with menopause at age > or =48, the hazard ratio (HR) of bladder cancer was 1.32 (95% CI; 0.90-1.94) for menopause at 43-47, and 1.60 (95% CI; 1.06-2.39) for < or =42 (p-trend = 0.02). The associations were similar for ages at natural and surgical menopause. In addition, women with a history of bilateral oophorectomy had an increased risk of bladder cancer compared with those who did not undergo bilateral oophorectomy: HR = 1.58 (95% CI; 1.12, 2.22). Finally, there was an indication of a positive association between bladder cancer and shorter lifetime years of ovulation (p-trend = 0.09). There were no associations between incident bladder cancer and age at first birth, number of births, age at menarche, use of hormone replacement therapy or any other reproductive characteristics. This study provides evidence that increased risk of bladder cancer is associated with earlier age at menopause in postmenopausal women. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2007        PMID: 17131327     DOI: 10.1002/ijc.22418

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  16 in total

1.  Lower risk in parous women suggests that hormonal factors are important in bladder cancer etiology.

Authors:  Carol A Davis-Dao; Katherine D Henderson; Jane Sullivan-Halley; Huiyan Ma; Dee West; Yong-Bing Xiang; Manuela Gago-Dominguez; Mariana C Stern; J Esteban Castelao; David V Conti; Malcolm C Pike; Leslie Bernstein; Victoria K Cortessis
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-04-14       Impact factor: 4.254

2.  Bladder cancer and reproductive factors among women in Spain.

Authors:  An-Tsun Huang; Manolis Kogevinas; Debra T Silverman; Nuria Malats; Nathaniel Rothman; Adonina Tardón; Consol Serra; Reina García-Closas; Alfredo Carrato; Kenneth P Cantor
Journal:  Cancer Causes Control       Date:  2009-12       Impact factor: 2.506

3.  Estrogen exposure and bladder cancer risk in Egyptian women.

Authors:  Beverly J Wolpert; Sania Amr; Sameera Ezzat; Doa'a Saleh; Iman Gouda; Iman Loay; Tamer Hifnawy; Nabiel N Mikhail; Mohamed Abdel-Hamid; Min Zhan; Yun-Ling Zheng; Katherine Squibb; Mohamed A Abdel-Aziz; Mohamed Zaghloul; Hussein Khaled; Christopher A Loffredo
Journal:  Maturitas       Date:  2010-09-01       Impact factor: 4.342

4.  Parity, early menopause and the incidence of bladder cancer in women: a case-control study and meta-analysis.

Authors:  K Dietrich; E Demidenko; A Schned; M S Zens; J Heaney; M R Karagas
Journal:  Eur J Cancer       Date:  2010-11-09       Impact factor: 9.162

5.  Oral Contraceptive Use and Risks of Cancer in the NIH-AARP Diet and Health Study.

Authors:  Kara A Michels; Louise A Brinton; Ruth M Pfeiffer; Britton Trabert
Journal:  Am J Epidemiol       Date:  2018-08-01       Impact factor: 4.897

6.  Reproductive factors and menopausal hormone therapy and bladder cancer risk in the NIH-AARP Diet and Health Study.

Authors:  Sarah E Daugherty; James V Lacey; Ruth M Pfeiffer; Yikyung Park; Robert N Hoover; Debra T Silverman
Journal:  Int J Cancer       Date:  2013-02-12       Impact factor: 7.396

7.  Raloxifene inhibits growth of RT4 urothelial carcinoma cells via estrogen receptor-dependent induction of apoptosis and inhibition of proliferation.

Authors:  Kristi L Hoffman; Seth P Lerner; Carolyn L Smith
Journal:  Horm Cancer       Date:  2012-09-11       Impact factor: 3.869

8.  The impact of hormones and reproductive factors on the risk of bladder cancer in women: results from the Nurses' Health Study and Nurses' Health Study II.

Authors:  Mohammad Abufaraj; Shahrokh Shariat; Marco Moschini; Florian Rohrer; Kyriaki Papantoniou; Elizabeth Devore; Monica McGrath; Xuehong Zhang; Sarah Markt; Eva Schernhammer
Journal:  Int J Epidemiol       Date:  2020-04-01       Impact factor: 7.196

9.  Body mass index modifies bladder cancer risk associated with low estrogen exposure among Egyptian women after menopause.

Authors:  Sania Amr; Beverly J Wolpert; Diane Marie St George; India James; Christopher A Loffredo
Journal:  Cancer Causes Control       Date:  2019-01-21       Impact factor: 2.506

10.  Estrogen receptor-β expression and pharmacological targeting in bladder cancer.

Authors:  Eric C Kauffman; Brian D Robinson; Martin Downes; Katarzyna Marcinkiewicz; Srinivas Vourganti; Douglas S Scherr; Lorraine J Gudas; Nigel P Mongan
Journal:  Oncol Rep       Date:  2013-04-23       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.